Runben Biotechnology Co., Ltd. (SHA:603193)

China · Delayed Price · Currency is CNY

21.96

-0.40 (-1.79%)

Jul 31, 2026, 3:00 PM CST

Runben Biotechnology Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,572	1,545	1,318	1,033	856.09	582.15
Revenue Growth	12.96%	17.19%	27.61%	20.66%	47.06%	31.46%
Gross Profit	917.6	898.19	764.98	579.62	462.81	306.4
Operating Income	335.45	327.87	303.08	242.62	177.34	130.58
Net Income	322.94	314.5	300.16	226.03	160.04	120.65
Earnings Per Share	0.80	0.78	0.74	0.64	0.47	0.36
EPS Growth	5.47%	5.41%	15.63%	36.17%	30.56%	16.13%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,142	1,469	1,434	1,603	376.45	262.43
Total Debt	1.06	1.42	2.78	4	7.91	10.31
Net Cash (Debt)	1,141	1,467	1,431	1,599	368.54	252.12
Net Cash Growth	-17.54%	2.56%	-10.52%	333.90%	46.18%	208.59%
Net Cash Per Share	2.82	3.64	3.53	4.53	1.08	0.75

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	291.89	275.26	257.24	252.52	165.32	138.65
Capital Expenditures	-115.97	-87.83	-74.22	-13.65	-40.65	-152.03
Free Cash Flow	175.92	187.42	183.02	238.87	124.67	-13.38
Free Cash Flow Growth	-5.94%	2.41%	-23.38%	91.60%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	58.38%	58.14%	58.03%	56.11%	54.06%	52.63%
Operating Margin	21.34%	21.22%	22.99%	23.49%	20.71%	22.43%
Pretax Margin	23.48%	23.45%	26.70%	25.94%	21.99%	24.33%
Profit Margin	20.54%	20.36%	22.77%	21.88%	18.70%	20.72%
FCF Margin	11.19%	12.13%	13.88%	23.13%	14.56%	-2.30%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Dividend Per Share	0.460	0.460	0.410	0.170
Dividend Per Share Growth	12.20%	12.20%	141.18%	-
Dividend Yield	2.09%	1.92%	1.80%	0.97%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	27.47	31.17	31.47	32.54	-	-
Forward PE	23.61	24.66	26.27	26.80	-	-
P/FCF Ratio	50.50	52.31	51.62	30.79	-	-
PS Ratio	5.65	6.35	7.17	7.12	-	-